UBS Group’s AGAPE ATP ATPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.81K Buy
+2,590
New +$8.26K ﹤0.01% 8650
2025
Q4
Sell
-165
Closed -$10.5K 10488
2025
Q3
$10.5K Sell
165
-413
-71% -$27.5K ﹤0.01% 8539
2025
Q2
$38.2K Buy
578
+505
+692% +$43.5K ﹤0.01% 7997
2025
Q1
$4.7K Sell
73
-1,315
-95% -$78.2K ﹤0.01% 9077
2024
Q4
$81.9K Buy
1,388
+937
+208% +$71.8K ﹤0.01% 6995
2024
Q3
$44K Buy
451
+430
+2,048% +$54.7K ﹤0.01% 6902
2024
Q2
$4.51K Buy
21
+17
+425% +$4.3K ﹤0.01% 8084
2024
Q1
$1.22K Buy
+4
New +$1.79K ﹤0.01% 8189

Other funds holding ATPC

UBS Group's ATPC Position: Q1 2026 in Review

UBS Group opened a new position in AGAPE ATP (ATPC) in Q1 2026: 2,590 shares worth $6.81K. The stake represents ﹤0.01% of the portfolio and ranks #8650 among its holdings. This is a return to the name: UBS Group previously reported a position in ATPC as recently as Q3 2025.

UBS Group first reported a position in ATPC in Q1 2024 and has held it in 8 quarters since. The position peaked at $81.9K in Q4 2024. 2 funds tracked by Wall St. Rank hold ATPC as of Q1 2026.

  • UBS Group held 2,590 shares of AGAPE ATP worth $6.81K as of Q1 2026.
  • AGAPE ATP was a new UBS Group position in Q1 2026.
  • AGAPE ATP made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8650 holding.
  • UBS Group first reported a position in AGAPE ATP in Q1 2024 and has held it in 8 quarters since.
  • UBS Group's AGAPE ATP position peaked at $81.9K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held AGAPE ATP as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.